ascopubs.org

Interstitial high dose rate (HDR) brachytherapy alone for early stage prostate cancer

Fixed infusion rate (FIR) gemcitabine (G) based treatment for advanced renal cell carcinoma (ARCC): Efficacy and toxicity data from a phase II study No significant financial relationships to disclose.
Nature

High-Dose-Rate Brachytherapy Techniques and Quality Assurance

High-dose-rate (HDR) brachytherapy represents a critical advancement in the delivery of radiotherapy by allowing high doses of radiation to be administered directly to tumours with minimal exposure to ...
ascopubs.org

Prostate cancer considered low or intermediate risk for biochemical failure according to the rtog-astro phoenix definition: Results of the use of neoadjuvant androgen ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting. This abstract does not include a full text component.
News Medical

Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...